Astec LifeSciences (ASTEC) Stock Overview
Manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ASTEC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Astec LifeSciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹720.80 |
| 52 Week High | ₹998.40 |
| 52 Week Low | ₹513.40 |
| Beta | -0.14 |
| 1 Month Change | 15.61% |
| 3 Month Change | 26.58% |
| 1 Year Change | 1.57% |
| 3 Year Change | -45.88% |
| 5 Year Change | -37.68% |
| Change since IPO | 758.10% |
Recent News & Updates
Recent updates
Astec LifeSciences Limited (NSE:ASTEC) Looks Just Right With A 33% Price Jump
Nov 25
Astec LifeSciences (NSE:ASTEC) Is Carrying A Fair Bit Of Debt
Nov 21The Price Is Right For Astec LifeSciences Limited (NSE:ASTEC) Even After Diving 30%
Feb 19Why We're Not Concerned About Astec LifeSciences Limited's (NSE:ASTEC) Share Price
Jan 04Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02Shareholder Returns
| ASTEC | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.8% | 0.09% | -0.9% |
| 1Y | 1.6% | -3.0% | 3.9% |
Return vs Industry: ASTEC exceeded the Indian Chemicals industry which returned -3% over the past year.
Return vs Market: ASTEC underperformed the Indian Market which returned 3.9% over the past year.
Price Volatility
| ASTEC volatility | |
|---|---|
| ASTEC Average Weekly Movement | 10.9% |
| Chemicals Industry Average Movement | 7.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.8% |
Stable Share Price: ASTEC's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: ASTEC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 555 | n/a | www.godrejastec.com |
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insecticides, and specialty chemical products.
Astec LifeSciences Limited Fundamentals Summary
| ASTEC fundamental statistics | |
|---|---|
| Market cap | ₹16.06b |
| Earnings (TTM) | -₹892.48m |
| Revenue (TTM) | ₹4.09b |
Is ASTEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASTEC income statement (TTM) | |
|---|---|
| Revenue | ₹4.09b |
| Cost of Revenue | ₹2.70b |
| Gross Profit | ₹1.39b |
| Other Expenses | ₹2.28b |
| Earnings | -₹892.48m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 27, 2026
| Earnings per share (EPS) | -40.05 |
| Gross Margin | 33.93% |
| Net Profit Margin | -21.82% |
| Debt/Equity Ratio | 88.6% |
How did ASTEC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/25 03:12 |
| End of Day Share Price | 2026/04/24 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Astec LifeSciences Limited is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Asian Markets Securities Private Limited |
| Ankur Periwal | Axis Capital Limited |
| Satish Kumar | CGS International |